Astrotech (ASTC) Subsidiary and Cleveland Clinic Partner to Develop a Rapid COVID-19 Breath Test
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
Astrotech (ASTC) Prices 7.826M Share Upsized Common Offering at $2.30/Sh
October 21, 2020 1:18 PM EDTAstrotech Corporation (NASDAQ: ASTC), today announced the pricing of a public offering of an aggregate of 7,826,086 shares of common stock, at a purchase price of $2.30 per share of common stock. The closing of the public offering is expected to occur on or about October 23, 2020,... More
Astrotech (ASTC) Surges on Development Deal with Cleveland Clinic for Rapid COVID-19 Breath Test
October 20, 2020 5:17 PM EDTAstrotech (NASDAQ: ASTC) is gaining 77% after-hours Tuesday after the company signed a joint development agreement (JDA) with Cleveland Clinic to explore leveraging Astrotechs BreathTest-1000 mass spectrometer to rapidly screen for COVID-19 or related indicators. The goal of the agreement is to develop a... More
